October 2020
Evaluation of the National Institute for Health and Care Excellence Diagnostics Assessment Program Decisions: Incremental Cost-Effectiveness Ratio Thresholds and Decision-Modifying Factors
Use of Real-World Evidence to Support FDA Approval of Oncology Drugs
Willingness to Pay for Health Improvements Using Stated Preferences: Prevention Versus Treatment
November 2020
Willingness to Accept Trade-Offs Among COVID-19 Cases, Social-Distancing Restrictions, and Economic Impact: A Nationwide US Study
Practical Guidance for Including Future Costs in Economic Evaluations in The Netherlands: Introducing and Applying PAID 3.0
Informing Balanced Investment in Services and Health Systems: A Case Study of Priority Setting for Tuberculosis Interventions in South Africa
Head-to-Head Comparison of the Psychometric Properties of 3 Carer-Related Preference-Based Instruments
December 2020
Alternative Approaches to Quality-Adjusted Life-Year Estimation Within Standard Cost-Effectiveness Models: Literature Review, Feasibility Assessment, and Impact Evaluation
Access and Unmet Needs of Orphan Drugs in 194 Countries and 6 Areas: A Global Policy Review With Content Analysis
Patient–Provider Discussion About Cancer Treatment Costs and Out-of-Pocket Spending: Implications for Shared Decision Making in Cancer Care
Nature and Predictors of Response Changes in Modified-Delphi Panels
Contribute to Value in Health
- Submit a manuscript/revision
- Become a peer reviewer
- Check manuscript status